European medical technology industry adopts new code of ethical business practice
Members of the European Diagnostics Manufacturers Association (EDMA) and of the European Medical Technology Industry (Eucomed), both members of MedTech Europe, have approved a new Code of Ethical Business Practice at their General Assemblies held on 2 December in Brussels, in a continuous effort to set high ethical standards for the medical technology industry across Europe.
European MedTech industry continues to reinforce its Codes of Ethical Business Practice
The Executive Committee of the European Diagnostics Manufacturers Association (EDMA) and the Board of the European Medical Technology Industry Association (Eucomed), both members of MedTech Europe, in a continuous effort to reinforce their respective Codes of Ethical Business Practice today announce their recommendation to members to phase out by 1 January 2018 direct industry sponsorship of healthcare professionals (HCPs) to third-party organised conferences. Both associations are also recommending the introduction of stricter rules for indirect sponsorship. The MedTech industry remains committed to supporting the continuing medical education of HCPs and will continue its ongoing consultation with HCP organisations and other stakeholders to ensure that HCPs have access to the education they need.